Literature DB >> 6313487

Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application.

C D Quentin, R Ansorg.   

Abstract

The penetration of cefotaxime, a new semi-synthetic cephalosporin, into human aqueous humour was investigated. Doses of 1 g (17 patients) and 2 g (19 patients) were administered intravenously at time intervals varying from 45 min to 4 h prior to routine cataract surgery. After the 2 g dosage the average concentration of cefotaxime in the aqueous humour was higher (P less than 0.05) and lasted longer than after the 1 g dosage. The highest average concentration in the aqueous humour after the 1 g dosage was 1.85 microgram/ml, 3.95 micrograms/ml after the 2 g dosage. Therapeutic levels were consistently found in both groups for the organisms most commonly responsible for bacterial endophthalmitis, except for Pseudomonas aeruginosa and Staphylococcus epidermidis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313487     DOI: 10.1007/bf02308083

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.

Authors:  J M Hamilton-Miller; W Brumfitt; A V Reynolds
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

3.  Intraocular penetration of cephaloridine.

Authors:  A B Richards; A J Bron; N S Rice; P Fells; M J Marshall; B R Jones
Journal:  Br J Ophthalmol       Date:  1972-07       Impact factor: 4.638

4.  [Aqueous-and serum levels of cephalexin and penicillin V after oral application in man (author's transl)].

Authors:  T Engels; J Ehrhorn; H Bleckmann
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-02-08

5.  Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.

Authors:  J P Sosna; P R Murray; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

6.  Penetration of intravenously administered cefoxitin into the aqueous humor of inflamed human eyes.

Authors:  J J Kanski; J H Young; R Vogel
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

7.  Management of infectious endophthalmitis.

Authors:  R K Forster; R L Abbott; H Gelender
Journal:  Ophthalmology       Date:  1980-04       Impact factor: 12.079

8.  In vitro of cefotaxime against cephalothin-resistant clinical isolates.

Authors:  H W Van Landuyt; M Pyckavet
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

9.  The intraocular penetration of cefuroxime after parenteral administration.

Authors:  A B Richards; A J Bron; B McLendon; M R Kennedy; S R Walker
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

10.  Moxalactam concentration in human aqueous humor after intravenous administration.

Authors:  J L Axelrod; R S Kochman
Journal:  Arch Ophthalmol       Date:  1982-08
View more
  1 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.